Answers are grounded in this paper and cite their sources.
Background Metastatic gastrointestinal neuroendocrine carcinoma (mGI-NEC) is known for its aggressive natural course with a short median overall survival (mOS). Currently, clinical tools guiding treatment strategy are lacking. We aimed to evaluate the prognostic impact of early depth of response (DpR). Patients and methods We conducted a retrospective study across 13 French centers. Consecutive patients with mGI-NEC treated with a platinum salt as first-line therapy between January 2010 and December 2023 were included. DpR was defined as the relative change in the sum of the largest diameters of target lesions on the first radiological assessment compared with baseline. Patients were stratified into 4 groups: (VGPR) (−100% to −60%); (PR) (−59% to −31%); (SD) (−30% to 0%); and (ITV) (0% or more). Multivariate Cox models, E-Values, bootstrap, and restrictive analyses were computed. Results Two hundred and twenty-nine patients with an mGI-NEC (colorectal for 28%, pancreatic for 24%) were included. mOS was 9.4 months. Seventy-five patients (33%) presented with ITV, 52 patients (23%) with SD, 70 patients (31%) with PR, and 32 patients (14%) with VGPR at first assessment (median of 2.1 months). mOS steadily decreased with the DpR. With SD as a reference, multivariate HR was 0.31 (0.19-0.50) for VGPR, 0.39 (0.27-0.58) for PR, and 2.17 (1.47-3.20) for ITV. Results of all sensitivity analyses were identical. Conclusion Early DpR was independently associated with OS and provided stronger prognostic discrimination than baseline factors. Prospective studies are warranted to determine whether DpR can guide risk-adapted treatment strategies.
No takes yet. Share an insight, caveat, or question.
Barbe-Richaud et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: